Nearly 1 in 5 positions across the Food and Drug Administration's human food inspection divisions are now vacant, multiple agency officials tell CBS News, in the wake of departures encouraged by the Trump administration's cost-cutting efforts and a government-wide hiring freeze that had stalled efforts to replenish their ranks.

Salmonella outbreaks linked to cucumbers have sickened hundreds of people since last year, drawing attention to the problem of contaminated irrigation water on farms.

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of birth control and may be harmful in pregnancy.

Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

But ketamine can still legally be prescribed by healthcare providers for unapproved uses if they determine it’s “medically appropriate” for their patient, according to the FDA. It’s similar to how the GLP-1 drug Ozempic is only FDA-approved to treat type two diabetes, but many people use it for weight loss.

An FDA Class II recall for the Publix baby food product indicates a remote but not negligible possibility of serious health issues being connected with it.

When Secretary of Health and Human Services Robert F. Kennedy Jr. announced an artificial food dye ban, it was difficult to determine its precise nature.

Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects.

The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the agency’s commissioner said.

The Trump administration on rescinded a Biden policy protecting emergency abortions at hospitals, even in states that have restricted access to abortion.

The U.S. Food and Drug Administration has rolled out a new AI assistant, Elsa, that it says will increase efficiency at its centers.